Pages that link to "Q37029023"
Jump to navigation
Jump to search
The following pages link to Intracellular antibodies (intrabodies) and their therapeutic potential (Q37029023):
Displaying 50 items.
- Antibodies inside of a cell can change its outside: Can intrabodies provide a new therapeutic paradigm? (Q26738467) (← links)
- Intracellular targeting with engineered proteins (Q26740106) (← links)
- Intrabodies as neuroprotective therapeutics (Q27003896) (← links)
- A novel hSH3 domain scaffold engineered to bind folded domains in CD2BP2 and HIV capsid protein (Q30010007) (← links)
- The influenza pandemic of 2009: lessons and implications (Q30403251) (← links)
- Physico-chemical determinants of soluble intrabody expression in mammalian cell cytoplasm (Q30980477) (← links)
- Selection for intrabody solubility in mammalian cells using GFP fusions (Q31035688) (← links)
- The toxin and antidote puzzle: new ways to control insect pest populations through manipulating inheritance (Q33352046) (← links)
- Engineering antibody fragments to fold in the absence of disulfide bonds (Q33403805) (← links)
- Direct injection of functional single-domain antibodies from E. coli into human cells (Q33775617) (← links)
- Use of micro-emulsion technology for the directed evolution of antibodies (Q34347039) (← links)
- Detection of biomarkers using recombinant antibodies coupled to nanostructured platforms (Q34352221) (← links)
- Semele: A Killer-Male, Rescue-Female System for Suppression and Replacement of Insect Disease Vector Populations (Q34537606) (← links)
- The use of fluorescent intrabodies to detect endogenous gankyrin in living cancer cells (Q34564636) (← links)
- Assessing combinatorial strategies to multimerize libraries of single-domain antibodies (Q34668664) (← links)
- Recombinant rabbit single-chain antibodies bind to the catalytic and C-terminal domains of HIV-1 integrase protein and strongly inhibit HIV-1 replication (Q34668776) (← links)
- Fine epitope mapping of the central immunodominant region of nucleoprotein from Crimean-Congo hemorrhagic fever virus (CCHFV) (Q35387209) (← links)
- Proteoliposome-based selection of a recombinant antibody fragment against the human M2 muscarinic acetylcholine receptor (Q35534895) (← links)
- A monoclonal antibody against the oncogenic mucin 1 cytoplasmic domain (Q35754887) (← links)
- Growth signalobody selects functional intrabodies in the mammalian cytoplasm (Q35863642) (← links)
- Intracellularly expressed nanobodies against non-structural protein 4 of porcine reproductive and respiratory syndrome virus inhibit virus replication. (Q35968646) (← links)
- In vivo selection of CD4(+) T cells transduced with a gamma-retroviral vector expressing a single-chain intrabody targeting HIV-1 tat. (Q36228890) (← links)
- Immunosympathectomy as the first phenotypic knockout with antibodies. (Q36729840) (← links)
- Novel therapeutic modalities to address nondrugable protein interaction targets (Q37255013) (← links)
- Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cells (Q37401812) (← links)
- Therapeutic antibodies: successes, limitations and hopes for the future (Q37491236) (← links)
- Developing intrabodies for the therapeutic suppression of neurodegenerative pathology (Q37571975) (← links)
- Regulation of β2-adrenergic receptor function by conformationally selective single-domain intrabodies. (Q37603933) (← links)
- From bench to bedside: the growing use of translational research in cancer medicine. (Q37698244) (← links)
- The state of antibody therapy (Q37789831) (← links)
- Antibody Therapy in Neurodegenerative Disease (Q37810562) (← links)
- Targeting antibodies to the cytoplasm (Q37811739) (← links)
- Engineered antibody therapies to counteract mutant huntingtin and related toxic intracellular proteins (Q37961564) (← links)
- Novel cell and gene therapies for HIV. (Q38048762) (← links)
- Gene-based antibody strategies for prion diseases (Q38136658) (← links)
- Aptamers: multifunctional molecules for biomedical research (Q38138814) (← links)
- Discovery of Therapeutic Approaches for Polyglutamine Diseases: A Summary of Recent Efforts (Q38792714) (← links)
- Cell-penetrating and endoplasmic reticulum-locating TAT-IL-24-KDEL fusion protein induces tumor apoptosis (Q38868901) (← links)
- Nanoparticles for the delivery of therapeutic antibodies: Dogma or promising strategy? (Q39049314) (← links)
- A novel recombinant protein TAT-GFP-KDEL with dual-function of penetrating cell membrane and locating at endoplasm reticulum. (Q39198282) (← links)
- Targeted delivery of PLK1-siRNA by ScFv suppresses Her2+ breast cancer growth and metastasis (Q39361870) (← links)
- Intrabodies binding the proline-rich domains of mutant huntingtin increase its turnover and reduce neurotoxicity (Q39943981) (← links)
- Intrabody-mediated diverting of HP1β to the cytoplasm induces co-aggregation of H3-H4 histones and lamin-B receptor (Q40544894) (← links)
- Intracellular Crosslinking of Filoviral Nucleoproteins with Xintrabodies Restricts Viral Packaging (Q41918644) (← links)
- An intrabody specific for the nucleophosmin carboxy-terminal mutant and fused to a nuclear localization sequence binds its antigen but fails to relocate it in the nucleus. (Q41964663) (← links)
- A bispecific transmembrane antibody simultaneously targeting intra- and extracellular epitopes of the epidermal growth factor receptor inhibits receptor activation and tumor cell growth (Q42628618) (← links)
- Phase I/II Clinical Trials Using Gene-Modified Adult Hematopoietic Stem Cells for HIV: Lessons Learnt (Q42760569) (← links)
- Nanobody-Based Delivery Systems for Diagnosis and Targeted Tumor Therapy (Q47121798) (← links)
- Engineering modular intracellular protein sensor-actuator devices. (Q54212048) (← links)
- Phenotypic knockouts of selected metabolic pathways by targeting enzymes with camel-derived nanobodies (V HH s) (Q57935539) (← links)